Department of Oncology, The 900th Hospital of the People's Liberation Army Joint Service Support Force, Fuzong Clinical Medical College of Fujian Medical University, Fuzhou, China.
Int J Colorectal Dis. 2021 Sep;36(9):1981-1993. doi: 10.1007/s00384-021-03992-w. Epub 2021 Jul 29.
The present study aimed to identify independent clinicopathological and socio-economic prognostic factors associated with overall survival of early-onset colorectal cancer (EO-CRC) patients and then establish and validate a prognostic nomogram for patients with EO-CRC.
Eligible patients with EO-CRC diagnosed from 2010 to 2017 were extracted from the Surveillance, Epidemiology, and End Results (SEER) database. Patients were randomly divided into a training cohort and a testing cohort. Independent prognostic factors were obtained using univariate and multivariate Cox analyses and were used to establish a nomogram for predicting 3- and 5-year overall survival (OS). The discriminative ability and calibration of the nomogram were assessed using C-index values, AUC values, and calibration plots.
In total, 5585 patients with EO-CRC were involved in the study. Based on the univariate and multivariate analyses, 15 independent prognostic factors were assembled into the nomogram to predict 3- and 5-year OS. The nomogram showed favorable discriminatory ability as indicated by the C-index (0.840, 95% CI 0.827-0.850), and the 3- and 5-year AUC values (0.868 and 0.84869 respectively). Calibration plots indicated optimal agreement between the nomogram-predicted survival and the actual observed survival. The results remained reproducible in the testing cohort. The C-index of the nomogram was higher than that of the TNM staging system (0.840 vs 0.804, P < 0.001).
A novel prognostic nomogram for EO-CRC patients based on independent clinicopathological and socio-economic factors was developed, which was superior to the TNM staging system. The nomogram could facilitate postoperative individual prognosis prediction and clinical decision-making.
本研究旨在确定与早发性结直肠癌(EO-CRC)患者总生存相关的独立临床病理和社会经济预后因素,并为 EO-CRC 患者建立和验证一个预后列线图。
从监测、流行病学和最终结果(SEER)数据库中提取 2010 年至 2017 年诊断为 EO-CRC 的合格患者。患者被随机分为训练队列和测试队列。使用单因素和多因素 Cox 分析获得独立的预后因素,并用于建立预测 3 年和 5 年总生存(OS)的列线图。使用 C 指数值、AUC 值和校准图评估列线图的判别能力和校准。
共纳入 5585 例 EO-CRC 患者。基于单因素和多因素分析,将 15 个独立的预后因素纳入列线图,以预测 3 年和 5 年 OS。列线图显示出良好的判别能力,C 指数为 0.840(95%CI 0.827-0.850),3 年和 5 年 AUC 值分别为 0.868 和 0.84869。校准图表明列线图预测的生存与实际观察的生存之间存在最佳一致性。在测试队列中结果仍然具有可重复性。列线图的 C 指数高于 TNM 分期系统(0.840 与 0.804,P < 0.001)。
基于独立的临床病理和社会经济因素,为 EO-CRC 患者开发了一种新的预后列线图,优于 TNM 分期系统。该列线图可以方便术后个体预后预测和临床决策。